Yes, sleep apnea can contribute to premature death. The strongest evidence concerns risk that builds over time, particularly cardiovascular risk, and the more immediate danger of a crash when sleepiness affects driving. That is different from saying a person will usually die during one ordinary apnea event.
In obstructive sleep apnea (OSA), a blocked airway reduces or stops airflow while breathing effort continues. The brain commonly responds by briefly arousing the person enough to reopen the airway, after which breathing restarts. In central sleep apnea (CSA), breathing effort falls or pauses because the brain is not sending the usual signals to breathe 1.
A witnessed pause that ends with a gasp is still a reason to arrange medical evaluation. If the person is unresponsive and is not breathing normally, however, do not assume it is "just sleep apnea." Treat that as a possible cardiac arrest and call emergency services 2.
Can someone die during a sleep apnea event?
A typical obstructive apnea is a repeating event: the airway closes, oxygen may fall, the brain triggers an arousal, and airflow returns. It may look frightening to a bed partner, but it is not the same event as a person becoming unresponsive and remaining unable to breathe 1.
Sleep apnea can still be part of a fatal chain of events. Repeated oxygen changes, sleep fragmentation, swings in nervous-system activity, and pressure changes in the chest place stress on the cardiovascular system. OSA is associated with high blood pressure, atrial fibrillation, coronary disease, heart failure, stroke, and cardiovascular death 3.
Researchers have also found an association between OSA and sudden cardiac death. In a sleep-clinic cohort of 10,701 adults, measures including apnea severity and lower overnight oxygen saturation predicted resuscitated or fatal sudden cardiac death during follow-up 4. This was an observational study of people referred for sleep testing. It cannot show that a particular apnea directly caused an individual death, and it does not provide a countdown for someone with OSA.
The practical distinction is:
| What you observe | What to do |
|---|---|
| The person has a brief pause, then resumes breathing and remains responsive when awakened | Arrange a medical evaluation for possible sleep apnea, especially if pauses recur |
| The person is unresponsive and not breathing normally, or is only gasping | Call your local emergency number, start CPR if instructed or trained, and use an AED if available |
| The person has severe chest pain, serious difficulty breathing, or new stroke signs | Call your local emergency number |
| The person is fighting sleep while driving | Stop driving and pull over in a safe place; do not rely on willpower to continue |
The American Heart Association advises lay rescuers to assume cardiac arrest when an adult is unresponsive and has absent or abnormal breathing, including gasping. Agonal breaths may look like slow, irregular gasping or snoring respirations, so gasping is not proof that the person is breathing normally 5.
What mortality studies actually show
Long-term studies consistently give more reason for concern about severe sleep apnea than mild disease, but their estimates do not translate into one person's absolute risk.
In the population-based Wisconsin Sleep Cohort, severe untreated sleep-disordered breathing was associated with higher all-cause mortality over long follow-up, including after researchers adjusted for age, sex, body mass index, and other measured factors 6. The study was observational. People were not randomly assigned to remain untreated, unmeasured differences may have affected the results, and estimates for cardiovascular death were imprecise because relatively few such deaths occurred.
A separate clinic-based study linked OSA with a higher combined risk of stroke or death after adjustment for several known risk factors 7. Again, an association is not proof that OSA caused every outcome. OSA shares risk factors with cardiovascular disease, including age and obesity, and people referred to a sleep clinic may differ from the general population.
These studies support taking sleep apnea seriously. They do not support claims that:
- Every untreated person will die early
- A specific oxygen reading predicts death
- Mild sleep apnea becomes fatal after a set number of years
- A person without obvious sleepiness is protected
- One treatment reduces risk to that of someone who never had sleep apnea
No study can use an apnea-hypopnea index (AHI) alone to predict whether or when one person will die.
Risk is more than the number of events per hour
The AHI counts apneas and hypopneas per hour of sleep. It is important for diagnosis and severity categories, but it treats events of different lengths and oxygen effects as though they were equivalent.
Research in two community cohorts found that sleep-apnea-specific hypoxic burden, a measure that incorporates the depth and duration of oxygen drops tied to breathing events, was associated with cardiovascular mortality even when AHI was less informative 8. This does not make hypoxic burden a stand-alone forecast of death. It shows why two people with the same AHI may not have the same physiological burden.
A clinician may consider several parts of the picture:
- OSA, CSA, or a mixture of obstructive and central events
- AHI and the pattern of events across sleep stages and positions
- Oxygen depth, duration, and cumulative burden
- Daytime sleepiness and safety-sensitive work or driving
- Age and existing heart, blood-vessel, lung, or neurologic disease
- Medicines or substances that affect breathing, including opioids
- Whether treatment is effective and used consistently
Symptoms are useful but incomplete. Some people with clinically important sleep apnea do not report severe sleepiness, and a person usually cannot observe their own breathing throughout the night.
Cardiovascular risk and crash risk are different
Cardiovascular risk usually concerns patterns that accumulate across months and years. Repeated airway obstruction can produce intermittent hypoxemia, autonomic changes, and sleep fragmentation. These mechanisms can help explain the observed links between OSA and hypertension, atrial fibrillation, coronary disease, heart failure, and stroke, but the contribution of sleep apnea varies from person to person 3.
Drowsy driving can create an immediate risk. A systematic review found that people with OSA had a higher motor-vehicle crash risk than controls, although the size of the estimate varied considerably across studies 9. OSA is not the only cause of drowsy driving, and not every person with OSA is sleepy. The safety decision is still simple: if you are struggling to stay awake, do not keep driving.
The National Highway Traffic Safety Administration warns that caffeine alone may not prevent microsleeps. If sleepiness begins while driving, pull over in a safe place. A short nap may provide temporary help, but it does not replace adequate sleep or treatment of the underlying cause 10.
Obstructive and central sleep apnea need different context
Most mortality research concerns OSA. It should not automatically be applied to every form of CSA.
CSA can occur with heart failure, opioid or other substance exposure, high altitude, another medical or neurologic condition, or without an identified cause. In some cases, the condition associated with CSA may account for part of the mortality risk. This makes it difficult to separate the effect of central events from the effect of the underlying illness.
Current AASM guidance recommends evaluating CSA in the context of symptoms, sleep-study findings, and contributing conditions. Treatment should prioritize the underlying cause as well as the breathing events, and the evidence for several CSA treatments remains limited 11.
Do not assume that a CPAP setting or treatment plan designed for OSA is appropriate for CSA. A clinician should review new central events, persistent events on treatment, opioid exposure, or relevant heart or neurologic disease.
Does treatment prevent death?
Effective treatment matters, but the evidence does not justify promising that it prevents every heart attack, stroke, or death.
Positive airway pressure (PAP) can keep the airway open, sharply reduce obstructive events while it is worn, and improve sleepiness and quality of life for many people. Other options, such as oral appliances, weight management, positional therapy, or selected procedures, may be appropriate depending on the cause, severity, anatomy, and patient preference 12.
Mortality and cardiovascular prevention are harder to study. In the randomized SAVE trial, adding CPAP to usual care did not reduce a composite of cardiovascular death and other major cardiovascular events among adults who already had cardiovascular disease and mostly had minimal sleepiness. Average CPAP use was 3.3 hours per night, while sleepiness and quality of life improved 13.
That result does not mean CPAP is ineffective or that treatment can be skipped. The trial addressed a specific population, excluded some very sleepy or severely hypoxemic patients, and achieved limited nightly use. It tested whether assignment to CPAP prevented a group of cardiovascular outcomes, not whether PAP controls airway obstruction.
An individual-participant meta-analysis of three cardiovascular-outcome trials likewise found no reduction in recurrent major cardiovascular and cerebrovascular events from CPAP assignment overall. In a separate on-treatment analysis, use of at least four hours per day was associated with lower event risk 14. Because adherence was not randomly assigned, that second comparison cannot prove cause and effect with the same confidence as the randomized comparison.
Treating sleep apnea improves breathing during sleep and can address symptoms and safety risks. Cardiovascular benefit may depend on the person, disease pattern, treatment effectiveness, and consistent use, while a guaranteed mortality benefit has not been established.
When to seek emergency care
Call your local emergency number now if a person:
- Is unresponsive and is not breathing normally, or is only gasping
- Has severe chest pain or pressure, especially with shortness of breath, sweating, nausea, or pain spreading to the arm, back, neck, jaw, or stomach
- Has serious difficulty breathing
- Develops sudden face drooping, arm weakness, speech trouble, loss of balance, or a sudden vision change
If an adult is unresponsive and not breathing normally, follow the emergency dispatcher's instructions, begin CPR if instructed or trained, and use an automated external defibrillator if one is available 5.
Do not drive yourself for care if you are struggling to stay awake, and do not ask a sleepy driver to take you. Call emergency services for emergency symptoms, or arrange an alert driver for non-emergency care.
When to arrange a sleep evaluation
Contact a healthcare professional if you or a bed partner notices:
- Repeated breathing pauses, gasping, choking, or loud habitual snoring
- Daytime sleepiness, especially during driving, work, or conversations
- Morning headaches, unrefreshing sleep, poor concentration, or unexplained fatigue
- New breathing events after starting PAP
- Persistent symptoms despite using prescribed treatment
Polysomnography is the standard diagnostic test when OSA is suspected. A technically adequate home sleep apnea test can be appropriate for some uncomplicated adults with a higher likelihood of moderate to severe OSA. A negative, inconclusive, or technically inadequate home test should be followed by polysomnography when suspicion remains 15.
A smartwatch, ring, phone app, PAP display, or single-channel pulse oximeter cannot rule sleep apnea in or out by itself. AASM guidance states that pulse oximetry alone is not an acceptable substitute for polysomnography or a multichannel home sleep apnea test in OSA follow-up 16.
Lack of snoring or severe sleepiness also does not rule it out. CSA may occur without loud obstruction-related sounds, and some people with OSA report few daytime symptoms.
Bottom line
Sleep apnea can contribute to premature death, but there is no evidence-based timeline that predicts death for one person. The main concerns are accumulated cardiovascular burden and preventable accidents related to sleepiness. Risk depends on more than AHI, and observational links do not prove that sleep apnea caused every heart attack, stroke, or death recorded in a study.
A usual apnea event often ends when breathing restarts after a brief arousal. An unresponsive person who is not breathing normally is different and needs emergency action. Repeated pauses, gasping, or daytime sleepiness warrant a proper sleep evaluation even if symptoms seem mild or a consumer device reports reassuring data.
Treatment should be selected for the type and cause of sleep apnea, then checked for effectiveness. It can improve breathing and daily function, but no therapy can be promised to eliminate all mortality risk.
